Resistance of human malignant intracranial tumors in vitro: potential guidelines to clinical therapy?
Tonn
J C
JC
Neurosurgical Department, University of Giessen, D-6300 Giessen, FRG.
Schönmayr
R
R
Kraemer
H P
HP
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000473:pathology*; D002330:Carmustine / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008954:Models, Biological; D015376:Nimustine / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D015376:Nimustine; D002330:Carmustine